-
Brigatinib, sold
under the
brand name
Alunbrig among others, is a small-molecule
targeted cancer therapy being developed by
Ariad Pharmaceuticals, Inc...
-
resistant to or
unable to
tolerate other tyrosine kinase inhibitors, and
brigatinib, a lung
cancer drug
which has
completed its
registration trial in ALK...
- osimertinib, crizotinib, daclatasvir, sofosbuvir, afatinib, axitinib,
brigatinib, baricitinib, cabozantinib, dasatinib, neratinib, eltrombopag, ibrutinib...
- "EGFR inhibitors", EGFRi),
including gefitinib, erlotinib, afatinib,
brigatinib and
icotinib for lung cancer, and
cetuximab for
colon cancer. More recently...
-
phase 3 ALEX
trial comparing it with crizotinib. Ariad's and Takeda's
brigatinib (also an
inhibitor of
mutated EGFR) was the
latest second-generation inhibitor...
-
Transforming growth factor alpha (TGFα)
Kinase inhibitors:
Afatinib Agerafenib Brigatinib Canertinib Dacomitinib Erlotinib Gefitinib Grandinin Icotinib Lapatinib...
-
Transforming growth factor alpha (TGFα)
Kinase inhibitors:
Afatinib Agerafenib Brigatinib Canertinib Dacomitinib Erlotinib Gefitinib Grandinin Icotinib Lapatinib...
-
Transforming growth factor alpha (TGFα)
Kinase inhibitors:
Afatinib Agerafenib Brigatinib Canertinib Dacomitinib Erlotinib Gefitinib Grandinin Icotinib Lapatinib...
-
Transforming growth factor alpha (TGFα)
Kinase inhibitors:
Afatinib Agerafenib Brigatinib Canertinib Dacomitinib Erlotinib Gefitinib Grandinin Icotinib Lapatinib...
-
treated with ALK
inhibitors crizotinib, or its
successors alectinib,
brigatinib, and ceritinib.
Those treated with ALK
inhibitors who
relapse can then...
